Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

Guardado en:
Detalles Bibliográficos
Autores principales: Mehmet Serdar Küçükoğlu, İsmail Hanta, Bahri Akdeniz, Sümeyye Güllülü, Ersan Atahan, Tamer Sayın, Gülfer Okumuş, Zeynep Pınar Önen, Mehmet Yokuşoğlu, Arzu Baygül
Formato: article
Lenguaje:EN
Publicado: KARE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/117c1f8116b64743b37c78b178f17e00
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:117c1f8116b64743b37c78b178f17e00
record_format dspace
spelling oai:doaj.org-article:117c1f8116b64743b37c78b178f17e002021-11-07T14:12:45ZClinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study10.5152/AnatolJCardiol.2021.030092149-22632149-2271https://doaj.org/article/117c1f8116b64743b37c78b178f17e002021-10-01T00:00:00Zhttps://anatoljcardiol.com/jvi.aspx?un=AJC-03009&volume=25&issue=10https://doaj.org/toc/2149-2263https://doaj.org/toc/2149-2271Mehmet Serdar Küçükoğluİsmail HantaBahri AkdenizSümeyye GüllülüErsan AtahanTamer SayınGülfer OkumuşZeynep Pınar ÖnenMehmet YokuşoğluArzu BaygülKARE PublishingarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENAnatolian Journal of Cardiology, Vol 25, Iss 10, Pp 721-732 (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Diseases of the circulatory (Cardiovascular) system
RC666-701
Mehmet Serdar Küçükoğlu
İsmail Hanta
Bahri Akdeniz
Sümeyye Güllülü
Ersan Atahan
Tamer Sayın
Gülfer Okumuş
Zeynep Pınar Önen
Mehmet Yokuşoğlu
Arzu Baygül
Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
format article
author Mehmet Serdar Küçükoğlu
İsmail Hanta
Bahri Akdeniz
Sümeyye Güllülü
Ersan Atahan
Tamer Sayın
Gülfer Okumuş
Zeynep Pınar Önen
Mehmet Yokuşoğlu
Arzu Baygül
author_facet Mehmet Serdar Küçükoğlu
İsmail Hanta
Bahri Akdeniz
Sümeyye Güllülü
Ersan Atahan
Tamer Sayın
Gülfer Okumuş
Zeynep Pınar Önen
Mehmet Yokuşoğlu
Arzu Baygül
author_sort Mehmet Serdar Küçükoğlu
title Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
title_short Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
title_full Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
title_fullStr Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
title_full_unstemmed Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
title_sort clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: data from prospective multicenter observational option study
publisher KARE Publishing
publishDate 2021
url https://doaj.org/article/117c1f8116b64743b37c78b178f17e00
work_keys_str_mv AT mehmetserdarkucukoglu clinicalefficacysafetytolerabilityandsurvivaloutcomeoflongterminhalediloprosttreatmentinthemanagementofpulmonaryarterialhypertensiondatafromprospectivemulticenterobservationaloptionstudy
AT ismailhanta clinicalefficacysafetytolerabilityandsurvivaloutcomeoflongterminhalediloprosttreatmentinthemanagementofpulmonaryarterialhypertensiondatafromprospectivemulticenterobservationaloptionstudy
AT bahriakdeniz clinicalefficacysafetytolerabilityandsurvivaloutcomeoflongterminhalediloprosttreatmentinthemanagementofpulmonaryarterialhypertensiondatafromprospectivemulticenterobservationaloptionstudy
AT sumeyyegullulu clinicalefficacysafetytolerabilityandsurvivaloutcomeoflongterminhalediloprosttreatmentinthemanagementofpulmonaryarterialhypertensiondatafromprospectivemulticenterobservationaloptionstudy
AT ersanatahan clinicalefficacysafetytolerabilityandsurvivaloutcomeoflongterminhalediloprosttreatmentinthemanagementofpulmonaryarterialhypertensiondatafromprospectivemulticenterobservationaloptionstudy
AT tamersayın clinicalefficacysafetytolerabilityandsurvivaloutcomeoflongterminhalediloprosttreatmentinthemanagementofpulmonaryarterialhypertensiondatafromprospectivemulticenterobservationaloptionstudy
AT gulferokumus clinicalefficacysafetytolerabilityandsurvivaloutcomeoflongterminhalediloprosttreatmentinthemanagementofpulmonaryarterialhypertensiondatafromprospectivemulticenterobservationaloptionstudy
AT zeyneppınaronen clinicalefficacysafetytolerabilityandsurvivaloutcomeoflongterminhalediloprosttreatmentinthemanagementofpulmonaryarterialhypertensiondatafromprospectivemulticenterobservationaloptionstudy
AT mehmetyokusoglu clinicalefficacysafetytolerabilityandsurvivaloutcomeoflongterminhalediloprosttreatmentinthemanagementofpulmonaryarterialhypertensiondatafromprospectivemulticenterobservationaloptionstudy
AT arzubaygul clinicalefficacysafetytolerabilityandsurvivaloutcomeoflongterminhalediloprosttreatmentinthemanagementofpulmonaryarterialhypertensiondatafromprospectivemulticenterobservationaloptionstudy
_version_ 1718443399278755840